New drug released to help CF patients
From the "This is what your donation does" department:
In February, the US FDA approved the drug Cayston as a treatment for cystic fibrosis. This drug was made possible by investment by the CF Foundation and its Therapeutics Development Program. Cayston is the first drug to advance from beginning to end through the program. The Therapeutics Development Program is designed to speed development of therapies for CF - therapies that may not have been otherwise worked on due to the relatively small patient population of CF.
For more information on CFF's role in the development and approval, please read the press release at the CFF website.
